Antitrust

A new alliance between Discovery Life Sciences and Mindpeak aims to solve inconsistent biomarker interpretation, a critical bottleneck in cancer drug development.

Dr. Chidebelu Ufodike brings large-scale retail healthcare expertise to NJ Urology, signaling a strategic push for operational efficiency and expansion.

At RSAC 2026, Swissbit is showcasing a groundbreaking security key roadmap, integrating post-quantum cryptography, biometric verification, and physical access.

With a strategic new hire, Storm Properties signals a major push into Southern California's complex residential market, betting on expertise to unlock land value.

With the appointment of Ben Wright as CRO, Insight Assurance signals a major push for global growth, leveraging AI to tackle complex cybersecurity regulations.

Millions of UK drivers may be owed compensation from a new FCA scheme. A free app from Equifax promises to help find the lost paperwork needed to claim.

Amid heightened antitrust scrutiny, HSF Kramer hires top lawyer David Pearl, bolstering its global competition practice and aggressive US growth strategy.

Behind closed doors, the world's top healthcare execs cut deals that define medical travel. What does this mean for patients and the future of global care?

With the FDA mandating a move from animal testing, BioIVT is positioning itself at the center of the NAMs revolution with key industry events and research.

Chicago Atlantic BDC declared a $0.34 dividend, offering a 13.7% yield. This article explores the high-stakes strategy of financing the cannabis boom.

A veteran advisor alleges Goldman Sachs gave him a 24-hour ultimatum to retire or be fired in a new arbitration claim alleging a pattern of age discrimination.

New LumiAgent AI lets users search video with simple sentences, part of a major security ecosystem push including robots and off-grid solutions.

A new book by a neurologist, attorney, and MBA argues that five powerful systems are contributing to a crisis in children's neurodevelopment.

Patent risk firm RPX hires Oliver Scherenberg to lead its European expansion, tackling the new Unified Patent Court and rising AI-related IP challenges.

A new study reveals over 211 fake legal cases, largely AI-generated, have infiltrated Canadian courts, threatening justice and hitting the vulnerable hardest.

Regulatory pressure ends a major ophthalmic deal, forcing LENSAR to forge ahead alone with its ALLY system and a $10M deposit. What's next?

As Cannabix rolls out its THC breathalyzer, a new tool emerges for employers and police. But can it truly distinguish recent use from impairment?

Actelion Pharmaceuticals settles a class action lawsuit for $65M, accused of illegally blocking a cheaper generic for its life-saving hypertension drug.

China's BABI launches a 4-in-1 sunscreen using patented tech and Nobel-inspired science to solve irritation, feel, and protection gaps.

Amid a complex healthcare market, The Ensign Group will outline its aggressive growth and operational playbook for investors at the upcoming Oppenheimer conference.